Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Nuclear Medicine

• Publication date

  2004-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 15001691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Bcl2-negative MCF7 cells overexpress p53: implications for the cell cycle and sensitivity to cytotoxic drugs

  2002cited by this paper
• Thymidylate synthase protein expression and activity are related to the cell proliferation rate in human cancer cell lines

  2002cited by this paper
• Bystander effect produced by radiolabeled tumor cells in vivo

  2002cited by this paper
• Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism.

  2002cited by this paper
• The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

  2002cited by this paper
• Thymidylate synthase (TS) and ribonucleotide reductase (RNR) may be involved in acquired resistance to 5-fluorouracil (5-FU) in human cancer xenografts in vivo.

  2001cited by this paper
• Characterization of a thymidylate synthase (TS)-inducible cell line: a model system for studying sensitivity to TS- and non-TS-targeted chemotherapies.

  2001cited by this paper
• Antisense‐induced down‐regulation of thymidylate synthase and enhanced cytotoxicity of 5‐FUdR in 5‐FUdR‐resistant HeLa cells

  2001cited by this paper
• Inhibition of thymidylate synthase activity by antisense oligodeoxynucleotide and possible role in thymineless treatment.

  2001cited by this paper
• Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.

  2001cited by this paper
• Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.

  2001cited by this paper
• Effect of 2'-O-methyl antisense ORNs on expression of thymidylate synthase in human colon cancer RKO cells.

  2001cited by this paper
• Immunological Gene Therapy with ex Vivo Gene-Modified Tumor Cells: A Critique and a Reappraisal

  2000cited by this paper
• Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase.

  2000cited by this paper
• Immunohistochemical quantitation of thymidylate synthase expression in colorectal cancer metastases predicts for clinical outcome to fluorouracil-based chemotherapy.

  1999cited by this paper
• Antisense down‐regulation of thymidylate synthase to suppress growth and enhance cytotoxicity of 5‐FUdR, 5‐FU and Tomudex in HeLa cells

  1999cited by this paper
• Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model

  1999cited by this paper
• A new prognostic factor for colorectal carcinoma, thymidylate synthase, and its therapeutic significance

  1998cited by this paper
• Electroporation‐mediated gene transfer in cardiac tissue

  1998cited by this paper
• Desensitization and sensitization of cells to fluoropyrimidines with different antisenses directed against thymidylate synthase messenger RNA.

  1998cited by this paper
• Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumour effectiveness by application of electric pulses in cancer patients.

  1998cited by this paper
• Gene transfer into muscle by electroporation in vivo.

  1998cited by this paper
• Direct gene transfer into rat liver cells by in vivo electroporation

  1998cited by this paper
• Indirect mechanisms contribute to biological effects produced by decay of DNA-incorporated iodine-125 in mammalian cells in vitro: double-strand breaks.

  1998cited by this paper
• Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

  1997cited by this paper
• Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.

  1997cited by this paper
• Modulation of [5-125I]iododeoxyuridine incorporation into tumour and normal tissue DNA by methotrexate and thymidylate synthase inhibitors.

  1996cited by this paper
• Radiolabeled iododeoxyuridine: safety evaluation.

  1996cited by this paper
• Identification of in vivo target RNA sequences bound by thymidylate synthase.

  1996cited by this paper
• Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy

  1996cited by this paper
• Kit formulation for the preparation of radiolabeled iododeoxyuridine by demetallation.

  1996cited by this paper
• Intratumoral administration of 5-[123I]iodo-2'-deoxyuridine in a patient with a brain tumor.

  1996cited by this paper
• Transfer of Genes to Humans: Early Lessons and Obstacles to Success

  1995cited by this paper
• High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes.

  1995cited by this paper
• Regression of bladder tumors in mice treated with interleukin 2 gene- modified tumor cells [published erratum appears in J Exp Med 1993 Jun 1;177(6):following 1831]

  1993cited by this paper
• Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.

  1991cited by this paper
• Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.

  1990cited by this paper
• Modulation of 5-iodo-2'-deoxyuridine metabolism and cytotoxicity in human bladder cancer cells by fluoropyrimidines.

  1985cited by this paper
• Clinical pharmacology of 5‐iodo‐2′‐deoxyuridine and 5‐iodouracil and endogenous pyrimidine modulation

  1985cited by this paper
• Thymidylate synthase gene amplification in fluorodeoxyuridine-resistant mouse cell lines.

  1985cited by this paper

• Effects of small interfering RNA targeting thymidylate synthase on survival of ACC3 cells from salivary adenoid cystic carcinoma

  2008cites this paper
• High‐throughput and real‐time study of single cell electroporation using microfluidics: Effects of medium osmolarity

  2006influential citation
• In Vivo Electroporation for Gene Therapy

  2006cites this paper
• Improved targeting of 5-[125I/131I]iodo-2′-deoxyuridine to rat hepatoma by using lipiodol emulsion

  2006cites this paper
• DNA uptake of 131I-iododeoxyuridine.

  2005cites this paper
• Hepatocyte growth factor gene therapy prevents radiation-induced liver damage.

  2005cites this paper
• Modulation of 5-fluorouracil cytotoxicity through thymidylate synthase and NF-kappaB down-regulation and its application on the radiolabelled iododeoxyuridine therapy on human hepatoma cell.

  2005cites this paper
• Why is the resolution of the Discovery PET/CT camera so poor?

  2005cites this paper